Clene Inc.

Healthcare

NASDAQ:CLNN · NASDAQ Capital Market

Market Cap $61.02M Beta 0.92 P/E (TTM) -2.1

$6.01 +1.35%

+$0.08 today

52W Low $3.25High $13.50

Vol 0.07M · Avg 0.50M

EPS (TTM) -$2.88Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+46.59%

Period High

$12.50

Period Low

$3.36

Latest

$6.01

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Ovid Therapeutics Inc.

NASDAQ:OVID

$311.91M

Zentalis Pharmaceuticals, Inc.

NASDAQ:ZNTL

$264.68M

MacroGenics, Inc.

NASDAQ:MGNX

$260.29M

Shattuck Labs, Inc.

NASDAQ:STTK

$234.25M

Whitehawk Therapeutics Inc

NASDAQ:WHWK

$213.63M

Oramed Pharmaceuticals Inc.

NASDAQ:ORMP

$156.75M

Connect Biopharma Holdings Limited

NASDAQ:CNTB

$126.56M

Coya Therapeutics, Inc.

NASDAQ:COYA

$89.04M

Pliant Therapeutics, Inc.

NASDAQ:PLRX

$71.21M

Context Therapeutics Inc.

NASDAQ:CNTX

$56.41M

What is the latest CLNN filing?

The latest filing shown is 4 dated Jun 15, 2026.

How many recent filings does CLNN have?

Intrinsic Alpha currently shows 20 recent filings for CLNN.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.